Select Net Receivables from 2010 to 2026

SEM Stock  USD 15.89  0.25  1.60%   
Select Medical Net Receivables yearly trend continues to be very stable with very little volatility. Net Receivables is likely to drop to about 601 M. During the period from 2010 to 2026, Select Medical Net Receivables quarterly data regression pattern had sample variance of 47362.1 T and median of  691,732,000. View All Fundamentals
 
Net Receivables  
First Reported
2006-06-30
Previous Quarter
909.5 M
Current Value
825.8 M
Quarterly Volatility
255.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Select Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Select Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 136.7 M, Interest Expense of 151.7 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 0.44, Dividend Yield of 0.029 or PTB Ratio of 1.37. Select financial statements analysis is a perfect complement when working with Select Medical Valuation or Volatility modules.
  
Build AI portfolio with Select Stock
Check out the analysis of Select Medical Correlation against competitors.
Evaluating Select Medical's Net Receivables across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Select Medical Holdings's fundamental strength.

Latest Select Medical's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Select Medical Holdings over the last few years. It is Select Medical's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Select Medical's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Select Net Receivables Regression Statistics

Arithmetic Mean648,744,253
Geometric Mean609,193,854
Coefficient Of Variation33.55
Mean Deviation181,833,350
Median691,732,000
Standard Deviation217,628,418
Sample Variance47362.1T
Range687.8M
R-Value0.82
Mean Square Error16304.7T
R-Squared0.68
Significance0.00005
Slope35,466,923
Total Sum of Squares757794.1T

Select Net Receivables History

2026601 M
2025944.6 M
2024821.4 M
2023724.1 M
2022941.3 M
2021889.3 M
2020896.8 M

About Select Medical Financial Statements

Select Medical investors utilize fundamental indicators, such as Net Receivables, to predict how Select Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables944.6 M601 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:
Will Health Care Providers & Services sector continue expanding? Could Select diversify its offerings? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Select Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.47)
Dividend Share
0.375
Earnings Share
0.82
Revenue Per Share
43.304
Quarterly Revenue Growth
0.072
Investors evaluate Select Medical Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Select Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Select Medical's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Select Medical's market price signifies the transaction level at which participants voluntarily complete trades.